11 results · 29ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

LED Light Therapy Device (Models: SG-FM, SG-FE)

FDA 510(k)
FDA Class 2 ·General, Plastic Surgery

ceraMotion®

FDA UDI
DENTAURUM GmbH & Co.KG·J011253086200·ceraMotion® Lf Shoulder transpa, 20 g / dental ...

RX ACCUNET Embolic Protection System

FDA 510(k)
FDA Class 2 ·Cardiovascular

MIE - GAMMA CAMERA SYSTEMS

FDA 510(k)
FDA Class 2 ·Radiology

DEXCOM G7 CONTINUOUS GLUCOSE MONITORING SYSTEM

FDA Adverse Event
Malfunction ·DEXCOM, INC.·Product code QBJ·September 10, 2025

LONG NAIL KIT R1.5, TI, RIGHT GAMMA3 10X260MM X 1

FDA Adverse Event
Injury ·STRYKER OSTEOSYNTHESIS KIEL·Product code HSB·August 28, 2012

MENTOR MEMORYGEL BREAST IMPLANT

FDA Adverse Event
Injury ·MENTOR TEXAS·Product code FTR·September 26, 2019

ZYPLAST COLLAGEN IMPLANT (1.0ML)

FDA Adverse Event
Injury ·INAMED CORP. (FREMONT)·Product code LMH·December 5, 2008

TOTALCARE BARIATRIC PLUS

FDA Adverse Event
Malfunction ·HILL-ROM, INC.·Product code FNL·August 31, 2011

KINETRA

FDA Adverse Event
Malfunction ·MEDTRONIC MED REL MEDTRONIC PUERTO RICO·Product code MHY·July 29, 2013

Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014